Detection of antibodies against hepatitis C virus in saliva: A marker of viral replication

Journal of Viral Hepatitis

Volumn 6, Issue 2, 1999, Pages 141-144

  Cameron, S O ^a,d   Wilson, K S ^a   Good, T ^a,d   McMenamin, J ^b   McCarron, B ^c   Pithie, A ^c   Fox, R ^c  

^a Regional Virus Laboratory   (United Kingdom)

^b Scottish Centre for Infection and Environmental Health   (United Kingdom)

^c Brownlee Centre for Infectious Diseases   (United Kingdom)

^d GARTNAVEL GENERAL HOSPITAL   (United Kingdom)

Author keywords

Antibody; Assay; HCV; RNA; Saliva

Indexed keywords

HEPATITIS C ANTIBODY; VIRUS RNA;

ANTIBODY DETECTION; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE MARKER; HEALTH SURVEY; HEPATITIS C; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SALIVA; SCREENING TEST; VIRUS DETECTION;

ADULT; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPACIVIRUS; HEPATITIS C; HEPATITIS C ANTIBODIES; HUMANS; MALE; MIDDLE AGED; RNA, VIRAL; SALIVA; VIRUS REPLICATION;

EID: 0033020390     PISSN: 13520504     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2893.1999.00142.x     Document Type: Article

References (11)

1. McIntyre PG, Laszlo J, Appleyard K, Ogden GR. Modified enzyme immunoassay to detect hepatitis C virus antibodies in oral fluid. Eur J Clin Microbiol Infect Dis 1996; 15: 882-884.
2. Sherman KE, Creager RI, O'Brien J, Sargent S, Piacentini S, Thieme T. The use of oral fluid for hepatitis C antibody screening. Am J Gastroenterol 1994; 89: 2025-2027.
3. Parry JV, Perry KR, Mortimer PP. Sensitive tests for viral antibodies in saliva: an alternative to tests on serum. Lancet 1987; 330: 72-75.
4. Thieme T, Yoshihara P, Piacentini S, Beller M. Clinical evaluation of oral fluid samples for diagnosis of viral hepatitis. J Clin Microbiol. 1992; 30: 1076-1079,
5. Piacentini SC, Thieme TR, Beller M, Davidson SL. Diagnosis of hepatitis A, B and C using oral fluids. Ann N Y Acad Sci 1993; 694: 334-336.
6. Bird AG, Gore SM, Hutchinson SJ, Lewis SC, Cameron S, Burns S. Harm reduction measures and injecting inside prison versus mandatory drugs testing: results of a cross sectional anonymous questionnaire survey. BMJ 1997; 315: 21-24.
7. Bellis MA, Weild AR, Beeching NK, Mutton KJ, Syed Q. Prevalence of HIV and injecting drug use in men entering a Liverpool prison. BMJ 1997; 315: 30-31.
8. Chan SW, McComish F, Holmes EC et al. Analysis of a new hepatitis C virus type and its phylogenetic relationship to existing variants. J Gen Virol 1992; 73: 1131-1141.
9. Goldberg D, Cameron S, McMenamin J. Hepatitis C virus antibody prevalence among intravenous drug users in Glasgow has fallen but remains high. Commun Dis Public Health 1998; 1: 1-3.
10. Dow BC, Buchanan I, Munro H et al. Relevance of RIBA-3 supplementary test to HCV PCR positivity and genotypes for HCV confirmation of blood donors. J Med Virol 1996; 49: 132-136.
11. Gore SM, Bird AG. Cross-sectional Willing Anonymous Salivary HIV (WASH) surveillance studies and self-completion risk factor questionnaire in establishments of the Scottish Prison Service. ANSWER (AIDS News Supplement to the Weekly Report), AM-15 WR95/39: 1-4.